カテゴリ： Infiniti Research TechNavio, 世界, 医療/バイオ

世界の加齢黄斑変性（AMD）市場2023～2027：ウェット型、ドライ型

■ 英語タイトル：Global Age-related Macular Degeneration Market 2023-2027

調査会社Technavio社が発行したリサーチレポート（データ管理コード：IRTNTR70644-23）■ 発行会社/調査会社：Technavio
■ 商品コード：IRTNTR70644-23
■ 発行日：2023年1月9日
■ 調査対象地域：北米、ヨーロッパ、アジア、その他の地域
■ 産業分野：医療
■ ページ数：154
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,500 ⇒換算￥380,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD4,000 ⇒換算￥608,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の加齢黄斑変性（AMD）市場2023～2027：ウェット型、ドライ型]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Technavio社の市場調査レポートでは、世界の加齢黄斑変性（AMD）市場規模が2022年から2027年の間に4,360.68百万ドルへ拡大し、予測期間中にCAGR 5.95%増加する見通しです。当調査レポートでは、加齢黄斑変性（AMD）の世界市場を調査対象とし、エグゼクティブサマリー、市場状況、市場規模・予測、過去の市場規模、ファイブフォース分析、種類別（ウェット型、ドライ型）分析、流通チャネル別（病院薬局、専門薬局、オンライン薬局）分析、顧客状況、地域別（北米、ヨーロッパ、アジア、その他地域、アメリカ、ドイツ、イギリス、フランス、日本）分析、成長要因・課題・動向、企業状況、企業分析などを整理しました。並びに、本レポートでは、AbbVie Inc., Adverum Biotechnologies Inc., Alimera Sciences Inc., Alkeus Pharmaceuticals Inc., Amgen Inc., Apellis Pharmaceuticals Inc., Bausch Health Co Inc., Bayer AG, Biocon Ltd., Bio-Thera Bio Pharmaceutical Co. Ltd., F. Hoffmann La Roche Ltd., IVERIC bio Inc., Lupin Ltd., Novartis AG, Outlook Therapeutics Inc., Pfizer Inc., Regeneron Pharmaceuticals Inc., Ribomic Inc., Viatris Inc., Xbrane Biopharma ABなどの企業情報が含まれております。
・エグゼクティブサマリー
・市場状況
・市場規模・予測
・過去の市場規模
・ファイブフォース分析
・世界の加齢黄斑変性（AMD）市場規模：種類別
- ウェット型加齢黄斑変性（AMD）の市場規模
- ドライ型加齢黄斑変性（AMD）の市場規模
・世界の加齢黄斑変性（AMD）市場規模：流通チャネル別
- 病院薬局チャネルの市場規模
- 専門薬局チャネルの市場規模
- オンライン薬局チャネルの市場規模
・顧客状況
・世界の加齢黄斑変性（AMD）市場規模：地域別
- 北米の加齢黄斑変性（AMD）市場
- ヨーロッパの加齢黄斑変性（AMD）市場
- アジアの加齢黄斑変性（AMD）市場
- その他地域の加齢黄斑変性（AMD）市場
- アメリカの加齢黄斑変性（AMD）市場
- ドイツの加齢黄斑変性（AMD）市場
- イギリスの加齢黄斑変性（AMD）市場
- フランスの加齢黄斑変性（AMD）市場
- 日本の加齢黄斑変性（AMD）市場
・成長要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益、価格、競争、プロモーションなどの主なパラメーターの解析によって得られた、複数の情報源からの情報を、調査・統合・総括することにより、市場の全体像を事細かに提示します。これらのデータは包括的​​で信頼性が高く、一次・二次の広範な研究の結果です。Technavio社の市場調査レポートは、確かな市場の成長を推測するための定性的、定量的調査を行い、完全な競争状況、そして詳細なベンダー選択方法と分析を提供します。

加齢黄斑変性（AMD）の世界市場 2023-2027

Technavio社は、加齢黄斑変性（AMD）市場をモニターしており、2022年から2027年にかけて4,360.68百万ドルの成長が予測され、予測期間中のCAGRは5.95%で加速すると予測しています。当レポートでは、加齢黄斑変性（AMD）市場について、市場規模や予測、動向、成長促進要因、課題などの全体的な分析に加え、約25のベンダーを網羅したベンダー分析も掲載しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。AMDの高い有病率、強力なパイプラインと承認見込み、老年人口の増加が市場を牽引しています。

Technavio社の加齢黄斑変性（AMD）市場は以下のように分類されます：

・タイプ別：
– ウェット型AMD
– ドライAMD

・流通チャネル別：
– 病院薬局
– 専門薬局
– オンライン薬局

・地域別：
– 北米
– ヨーロッパ
– アジア
– その他の地域（ROW）

本調査では、戦略的提携が今後数年間の加齢黄斑変性（AMD）市場の成長を促進する主要な理由の1つであると特定しています。また、加齢黄斑変性（AMD）に対する遺伝子治療の開発と加齢黄斑変性（AMD）に対する意識の高まりが、市場の大きな需要につながるとしています。

Technavio社は、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。

当レポートでは、加齢黄斑変性（AMD）市場について以下の分野をカバーしています：
– 加齢黄斑変性（AMD）市場のサイジング
– 加齢黄斑変性（AMD）市場予測
– 加齢黄斑変性（AMD）市場産業分析

Technavio社の確実なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートには、AbbVie Inc., Adverum Biotechnologies Inc., Alimera Sciences Inc., Alkeus Pharmaceuticals Inc., Amgen Inc., Apellis Pharmaceuticals Inc., Bausch Health Co Inc., Bayer AG, Biocon Ltd., Bio-Thera Bio Pharmaceutical Co. Ltd., F. Hoffmann La Roche Ltd., IVERIC bio Inc., Lupin Ltd., Novartis AG, Outlook Therapeutics Inc., Pfizer Inc., Regeneron Pharmaceuticals Inc., Ribomic Inc., Viatris Inc., and Xbrane Biopharma ABなどの企業情報が含まれています。また、加齢黄斑変性（AMD）市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートでは、主要ベンダーの分析に加え、包括的な市場およびベンダーの状況を掲載しています。

Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細な姿を提示します。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。

Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market by Geography
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global age-related macular degeneration market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global age-related macular degeneration market 2017 – 2021 ($ million)
o 4.2 Type Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Type Segment 2017 – 2021 ($ million)
o 4.3 Distribution Channel Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Distribution Channel Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Type – Market share 2022-2027 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Wet AMD – Market size and forecast 2022-2027
o Exhibit 34: Chart on Wet AMD – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Wet AMD – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Wet AMD – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Wet AMD – Year-over-year growth 2022-2027 (%)
o 6.4 Dry AMD – Market size and forecast 2022-2027
o Exhibit 38: Chart on Dry AMD – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Dry AMD – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Dry AMD – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Dry AMD – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ million)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 43: Chart on Distribution Channel – Market share 2022-2027 (%)
o Exhibit 44: Data Table on Distribution Channel – Market share 2022-2027 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 45: Chart on Comparison by Distribution Channel
o Exhibit 46: Data Table on Comparison by Distribution Channel
o 7.3 Hospital pharmacy – Market size and forecast 2022-2027
o Exhibit 47: Chart on Hospital pharmacy – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Data Table on Hospital pharmacy – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Chart on Hospital pharmacy – Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on Hospital pharmacy – Year-over-year growth 2022-2027 (%)
o 7.4 Specialty pharmacy – Market size and forecast 2022-2027
o Exhibit 51: Chart on Specialty pharmacy – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Specialty pharmacy – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Specialty pharmacy – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Specialty pharmacy – Year-over-year growth 2022-2027 (%)
o 7.5 Online pharmacy – Market size and forecast 2022-2027
o Exhibit 55: Chart on Online pharmacy – Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on Online pharmacy – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on Online pharmacy – Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Online pharmacy – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Distribution Channel
o Exhibit 59: Market opportunity by Distribution Channel ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 61: Chart on Market share by geography 2022-2027 (%)
o Exhibit 62: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 63: Chart on Geographic comparison
o Exhibit 64: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 65: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 67: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 69: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 73: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 81: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Germany – Market size and forecast 2022-2027
o Exhibit 85: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.9 UK – Market size and forecast 2022-2027
o Exhibit 89: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.10 France – Market size and forecast 2022-2027
o Exhibit 93: Chart on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on France – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on France – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 97: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 101: Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 102: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 104: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 105: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 106: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 107: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 108: AbbVie Inc. – Overview
o Exhibit 109: AbbVie Inc. – Product / Service
o Exhibit 110: AbbVie Inc. – Key news
o Exhibit 111: AbbVie Inc. – Key offerings
o 12.4 Alkeus Pharmaceuticals Inc.
o Exhibit 112: Alkeus Pharmaceuticals Inc. – Overview
o Exhibit 113: Alkeus Pharmaceuticals Inc. – Product / Service
o Exhibit 114: Alkeus Pharmaceuticals Inc. – Key offerings
o 12.5 Amgen Inc.
o Exhibit 115: Amgen Inc. – Overview
o Exhibit 116: Amgen Inc. – Product / Service
o Exhibit 117: Amgen Inc. – Key offerings
o 12.6 Apellis Pharmaceuticals Inc.
o Exhibit 118: Apellis Pharmaceuticals Inc. – Overview
o Exhibit 119: Apellis Pharmaceuticals Inc. – Product / Service
o Exhibit 120: Apellis Pharmaceuticals Inc. – Key offerings
o 12.7 Bausch Health Co Inc.
o Exhibit 121: Bausch Health Co Inc. – Overview
o Exhibit 122: Bausch Health Co Inc. – Business segments
o Exhibit 123: Bausch Health Co Inc. – Key news
o Exhibit 124: Bausch Health Co Inc. – Key offerings
o Exhibit 125: Bausch Health Co Inc. – Segment focus
o 12.8 Bayer AG
o Exhibit 126: Bayer AG – Overview
o Exhibit 127: Bayer AG – Business segments
o Exhibit 128: Bayer AG – Key news
o Exhibit 129: Bayer AG – Key offerings
o Exhibit 130: Bayer AG – Segment focus
o 12.9 Biocon Ltd.
o Exhibit 131: Biocon Ltd. – Overview
o Exhibit 132: Biocon Ltd. – Business segments
o Exhibit 133: Biocon Ltd. – Key offerings
o Exhibit 134: Biocon Ltd. – Segment focus
o 12.10 Bio-Thera Bio Pharmaceutical Co. Ltd.
o Exhibit 135: Bio-Thera Bio Pharmaceutical Co. Ltd. – Overview
o Exhibit 136: Bio-Thera Bio Pharmaceutical Co. Ltd. – Product / Service
o Exhibit 137: Bio-Thera Bio Pharmaceutical Co. Ltd. – Key offerings
o 12.11 F. Hoffmann La Roche Ltd.
o Exhibit 138: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 139: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 140: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 141: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 142: F. Hoffmann La Roche Ltd. – Segment focus
o 12.12 IVERIC bio Inc.
o Exhibit 143: IVERIC bio Inc. – Overview
o Exhibit 144: IVERIC bio Inc. – Product / Service
o Exhibit 145: IVERIC bio Inc. – Key offerings
o 12.13 Lupin Ltd.
o Exhibit 146: Lupin Ltd. – Overview
o Exhibit 147: Lupin Ltd. – Product / Service
o Exhibit 148: Lupin Ltd. – Key news
o Exhibit 149: Lupin Ltd. – Key offerings
o 12.14 Novartis AG
o Exhibit 150: Novartis AG – Overview
o Exhibit 151: Novartis AG – Business segments
o Exhibit 152: Novartis AG – Key offerings
o Exhibit 153: Novartis AG – Segment focus
o 12.15 Outlook Therapeutics Inc.
o Exhibit 154: Outlook Therapeutics Inc. – Overview
o Exhibit 155: Outlook Therapeutics Inc. – Product / Service
o Exhibit 156: Outlook Therapeutics Inc. – Key offerings
o 12.16 Pfizer Inc.
o Exhibit 157: Pfizer Inc. – Overview
o Exhibit 158: Pfizer Inc. – Product / Service
o Exhibit 159: Pfizer Inc. – Key news
o Exhibit 160: Pfizer Inc. – Key offerings
o 12.17 Regeneron Pharmaceuticals Inc.
o Exhibit 161: Regeneron Pharmaceuticals Inc. – Overview
o Exhibit 162: Regeneron Pharmaceuticals Inc. – Product / Service
o Exhibit 163: Regeneron Pharmaceuticals Inc. – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 164: Inclusions checklist
o Exhibit 165: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 166: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 167: Research methodology
o Exhibit 168: Validation techniques employed for market sizing
o Exhibit 169: Information sources
o 13.5 List of abbreviations
o Exhibit 170: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market by Geography
Exhibits5: Executive Summary – Chart on Market Segmentation by Type
Exhibits6: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global age-related macular degeneration market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Type Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Distribution Channel Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Type – Market share 2022-2027 (%)
Exhibits31: Data Table on Type – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Wet AMD – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Wet AMD – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Wet AMD – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Wet AMD – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Dry AMD – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Dry AMD – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Dry AMD – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Dry AMD – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Chart on Distribution Channel – Market share 2022-2027 (%)
Exhibits44: Data Table on Distribution Channel – Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by Distribution Channel
Exhibits46: Data Table on Comparison by Distribution Channel
Exhibits47: Chart on Hospital pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits48: Data Table on Hospital pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits49: Chart on Hospital pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Hospital pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Specialty pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Specialty pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Specialty pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Specialty pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Online pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Online pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Online pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Online pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits59: Market opportunity by Distribution Channel ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share by geography 2022-2027 (%)
Exhibits62: Data Table on Market share by geography 2022-2027 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on France – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on France – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on France – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on France – Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits101: Market opportunity by geography ($ million)
Exhibits102: Impact of drivers and challenges in 2022 and 2027
Exhibits103: Overview on Criticality of inputs and Factors of differentiation
Exhibits104: Overview on factors of disruption
Exhibits105: Impact of key risks on business
Exhibits106: Vendors covered
Exhibits107: Matrix on vendor position and classification
Exhibits108: AbbVie Inc. – Overview
Exhibits109: AbbVie Inc. – Product / Service
Exhibits110: AbbVie Inc. – Key news
Exhibits111: AbbVie Inc. – Key offerings
Exhibits112: Alkeus Pharmaceuticals Inc. – Overview
Exhibits113: Alkeus Pharmaceuticals Inc. – Product / Service
Exhibits114: Alkeus Pharmaceuticals Inc. – Key offerings
Exhibits115: Amgen Inc. – Overview
Exhibits116: Amgen Inc. – Product / Service
Exhibits117: Amgen Inc. – Key offerings
Exhibits118: Apellis Pharmaceuticals Inc. – Overview
Exhibits119: Apellis Pharmaceuticals Inc. – Product / Service
Exhibits120: Apellis Pharmaceuticals Inc. – Key offerings
Exhibits121: Bausch Health Co Inc. – Overview
Exhibits122: Bausch Health Co Inc. – Business segments
Exhibits123: Bausch Health Co Inc. – Key news
Exhibits124: Bausch Health Co Inc. – Key offerings
Exhibits125: Bausch Health Co Inc. – Segment focus
Exhibits126: Bayer AG – Overview
Exhibits127: Bayer AG – Business segments
Exhibits128: Bayer AG – Key news
Exhibits129: Bayer AG – Key offerings
Exhibits130: Bayer AG – Segment focus
Exhibits131: Biocon Ltd. – Overview
Exhibits132: Biocon Ltd. – Business segments
Exhibits133: Biocon Ltd. – Key offerings
Exhibits134: Biocon Ltd. – Segment focus
Exhibits135: Bio-Thera Bio Pharmaceutical Co. Ltd. – Overview
Exhibits136: Bio-Thera Bio Pharmaceutical Co. Ltd. – Product / Service
Exhibits137: Bio-Thera Bio Pharmaceutical Co. Ltd. – Key offerings
Exhibits138: F. Hoffmann La Roche Ltd. – Overview
Exhibits139: F. Hoffmann La Roche Ltd. – Business segments
Exhibits140: F. Hoffmann La Roche Ltd. – Key news
Exhibits141: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits142: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits143: IVERIC bio Inc. – Overview
Exhibits144: IVERIC bio Inc. – Product / Service
Exhibits145: IVERIC bio Inc. – Key offerings
Exhibits146: Lupin Ltd. – Overview
Exhibits147: Lupin Ltd. – Product / Service
Exhibits148: Lupin Ltd. – Key news
Exhibits149: Lupin Ltd. – Key offerings
Exhibits150: Novartis AG – Overview
Exhibits151: Novartis AG – Business segments
Exhibits152: Novartis AG – Key offerings
Exhibits153: Novartis AG – Segment focus
Exhibits154: Outlook Therapeutics Inc. – Overview
Exhibits155: Outlook Therapeutics Inc. – Product / Service
Exhibits156: Outlook Therapeutics Inc. – Key offerings
Exhibits157: Pfizer Inc. – Overview
Exhibits158: Pfizer Inc. – Product / Service
Exhibits159: Pfizer Inc. – Key news
Exhibits160: Pfizer Inc. – Key offerings
Exhibits161: Regeneron Pharmaceuticals Inc. – Overview
Exhibits162: Regeneron Pharmaceuticals Inc. – Product / Service
Exhibits163: Regeneron Pharmaceuticals Inc. – Key offerings
Exhibits164: Inclusions checklist
Exhibits165: Exclusions checklist
Exhibits166: Currency conversion rates for US$
Exhibits167: Research methodology
Exhibits168: Validation techniques employed for market sizing
Exhibits169: Information sources
Exhibits170: List of abbreviations



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の胃食道逆流症（GERD）市場2023～2027：経口剤、非経口剤
  • 世界のマイクロバイオーム（微生物叢）市場2023～2027：治療薬、診断薬
  • 世界の寒天（アガー）市場2023～2027：粉体、フレーク、シート
  • 世界の医薬品研究製造＆受託（CRAM）市場2023-2027：CMO、CRO
  • 世界の個人用緊急応答システム（PERS）市場2023～2027：携帯型、固定電話型、独立型
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(IRTNTR70644-23 )"世界の加齢黄斑変性（AMD）市場2023～2027：ウェット型、ドライ型" (英文：Global Age-related Macular Degeneration Market 2023-2027)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。